Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel.

Date publication

février 2017

Journal

The British journal of dermatology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr CRIBIER Bernard

Tous les auteurs :
Tan J, Almeida LM, Bewley A, Cribier B, Dlova NC, Gallo R, Kautz G, Mannis M, Oon HH, Rajagopalan M, Steinhoff M, Thiboutot D, Troielli P, Webster G, Wu Y, van Zuuren EJ, Schaller M

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/27718519

Résumé

Rosacea is currently diagnosed by consensus-defined primary and secondary features and managed by subtype. However, individual features (phenotypes) can span multiple subtypes, which has implications for clinical practice and research. Adopting a phenotype-led approach may facilitate patient-centred management.

Mots clés

Age of Onset, Consensus, Cost of Illness, Dermatitis, etiology, Dermatologists, Eye Diseases, classification, Humans, International Cooperation, Life Style, Ophthalmologists, Patient Care Planning, Rosacea, classification, Severity of Illness Index, Skin Pigmentation, physiology, Telangiectasis, etiology

Référence

Br. J. Dermatol.. 2017 Feb;176(2):431-438